Article contents
The eye in CHD
Published online by Cambridge University Press: 25 July 2018
Abstract
In recent years, there has been a rise in the number patients with CHD surviving into adulthood. Many have complications related to their CHD or its treatments, outside the heart, including ocular abnormalities. The objective of this review is to highlight the ocular abnormalities that occur in adults with CHD, either from their condition or related to the common drugs prescribed to manage it. In particular, we reviewed the effects of cyanosis, coarctation of the aorta, endocarditis, and the side effects of Sildenafil and Amiodarone. A change in the retinal vasculature is a common observation with cyanosis or coarctation of the aorta. Occlusion of the retinal vessels may also be observed in cyanotic patients, as well as those with infectious endocarditis. Sildenafil has established ocular side effects; here they are explored in the context of therapy for pulmonary hypertension. Similarly, Amiodarone has established ocular risks, which are summarised. The high prevalence of ocular consequences in adult CHD patients reinforces the need for knowledge of the risks involved and for frequent ophthalmological screening where appropriate.
- Type
- Review Article
- Information
- Copyright
- © Cambridge University Press 2018
Footnotes
Cite this article: Nasir-Ahmad S, Cordina R, Liew G, McCluskey P, Celermajer D. (2018) The eye in CHD. Cardiology in the Young28: 981–985. doi: 10.1017/S1047951118000859
References
- 7
- Cited by